Clinical Trial Update: Revlimid in Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update reporting results for lenalidomide (Revlimid) in patients with acute myeloid leukemia and myelodysplastic syndromes, wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Revlimid (lenalidomide)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Acute Myelogenous Leukemia, Myelodysplastic Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2013-08-01